Geneticists Engineer a Virus to Fight Citrus Disease

Scientists hope to save oranges from a bacterial disease that causes citrus greening, a disease that leads to bitter, discolored fruit.

Written byDiana Kwon
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, RAFAEL CASTILLO

Since 2005, Candidatus Liberibacter, a genus of bacteria that is spread by Asian citrus psyllids (Diaphorina citri) and turns fruit green and bitter, has been devastating orange crops in the United States. “There’s a real race on right now to try to save the citrus,” Carolyn Slupsky, a food scientist at the University of California, Davis, told Nature. “This disease is everywhere, and it’s horrible.”

To combat this rapidly spreading pathogen, scientists at the Florida-based agricultural company Southern Gardens Citrus engineered a harmless strain of the citrus tristeza virus (CTV) to produce genes isolated from spinach plants that fight off the harmful bacteria. The company plans to infect tree limbs with this virus then graft them onto the bacteria-infected trees.

“We’re attacking the bacteria where ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies